API reference

Levodopa

CAS number
59-92-7
Molecular formula
C9H11NO4
Molecular weight
197.19 g/mol
Levodopa — 2D structure
2D structure (PubChem)

About this molecule

Levodopa is an amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. When in the brain, levodopa is decarboxylated to dopamine and stimulates the dopaminergic receptors, thereby compensating for the depleted supply of endogenous dopamine seen in Parkinson's disease. To assure that adequate concentrations of levodopa reach the central nervous system, it is administered with carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier, thereby diminishing the decarboxylation and inactivation of levodopa in peripheral tissues and increasing the delivery of dopamine to the CNS.

Source: NCI Thesaurus (NCIt), via PubChem.

Identifiers

IUPAC name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
InChIKey
WTDRDQBEARUVNC-LURJTMIESA-N
SMILES
C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
Other CAS numbers recorded
65170-01-6 · 122769-74-8
PubChem CID
6047

Also known as

levodopa · L-dopa · 3,4-dihydroxy-L-phenylalanine · Dopar · 3-Hydroxy-L-tyrosine · Larodopa · Bendopa · 3-(3,4-Dihydroxyphenyl)-L-alanine

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com